Navidea Biopharmaceuticals, Inc. (NAVB) has 20 known insider and institutional holders on record. The largest holder is Scott John K Jr. with 31,755,832 shares. Other notable holders include Nordlicht Mark and Platinum-Montaur Life Sciences, LLC.
NAVB Insider Ownership
Top Holder
Scott John K Jr.
31,755,832 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Scott John K Jr. |
10 Percent Owner |
31,755,832 |
2023-06-30 |
|
| 2 |
Nordlicht Mark |
10 Percent Owner |
14,946,431 |
2014-09-04 |
|
| 3 |
Platinum-montaur Life Sciences, Llc |
Officer |
10,073,375 |
2013-11-25 |
|
| 4 |
Goldberg Michael M |
Officer |
5,921,023 |
2017-05-16 |
|
| 5 |
Bupp David C |
Director |
2,900,328 |
2011-12-20 |
|
| 6 |
Cope Frederick O |
SVP & CSO |
585,052 |
2018-07-13 |
|
| 7 |
Stefanelli Jill |
Director |
525,000 |
2023-11-20 |
|
| 8 |
Moss Dana J |
Director |
450,000 |
2023-11-20 |
|
| 9 |
Pykett Mark Jerome |
Director |
312,674 |
2014-06-03 |
|
| 10 |
Troup Gordon A |
Director |
265,568 |
2016-05-03 |
|
| 11 |
Ford Brendan A |
Director |
239,950 |
2015-08-03 |
|
| 12 |
Rowinsky Eric K |
Director |
173,764 |
2018-02-22 |
|
| 13 |
Regan William J. |
SVP & Cco |
172,977 |
2017-07-03 |
|
| 14 |
Witter Malcolm G |
Director |
163,888 |
2022-11-30 |
|
| 15 |
Aschinger Carl J Jr |
Director |
158,300 |
2011-05-31 |
|
| 16 |
Avital Reuven |
Director |
150,000 |
2010-03-18 |
|
| 17 |
Reininger Cornelia |
SVP & Chief Medical Officer |
143,000 |
2014-01-31 |
|
| 18 |
Brown Rodger A |
Vice President |
123,027 |
2013-03-15 |
|
| 19 |
Rosol Michael Stanley |
Chief Medical Officer |
100,000 |
2022-03-08 |
|
| 20 |
Greene Mark I |
Director |
100,000 |
2018-02-22 |
|
No ownership data available for NAVB.
